British pharma giant GSK on Wednesday announced promising results for a long-acting injectable HIV therapy, offering a hopeful alternative for people who take daily pills to halt the virus’s ...

Human trials of a once-a-week oral pill for HIV could start, after successful tests in pigs, claim US scientists. The slow-release tablet could free patients from having to take daily medication ...